MANILA, Philippines, Aug. 13, 2025 -- The Philippine government has partnered with the country's leading e-wallet in line with its agenda to modernize the local transportation sector with world-class payment solutions. The Department of Transportation (DOTr), the country's central bank, Bangko Sentral ng Pilipinas (BSP), the Department of Information and Communications Technology (DICT), and leading local fintech giant GCash have launched world-class cashless solutions in Metro Manila's main rail line, the Metro Rail Transit System Line 3 (MRT-3). This initiative positio
BEIJING, Aug. 13, 2025 -- A news report from chinadaily.com.cn Dunhuang, a timeless gem in Gansu province, China, echoes the spirit of the Silk Road. Explore breathtaking landscapes at Yardang National Geopark, indulge in local delicacies at the lively Dunhuang night market, and discover the artistry of the Mogao Caves, famed for their enchanting flying dance murals. Join ballet dancer Sabrina on a mesmerizing cultural journey through this ancient city, where history and hospitality intertwine.
[ 메디채널 김갑성 기자 ] 정밀 의료 접근성 향상 위해 규제 및 시스템적 개선 필요 서울, 대한민국, 2025년 8월 13일 -- 글로벌 전략 컨설팅 기업 'L.E.K. 컨설팅'이 오늘 발표한 백서 '정밀 의료 사례 연구 보고서(On the Cusp of a Cure)'에 따르면, 정밀 의료 시대가 본격화되면 향후 10년간 한국에서 약 60조 원의 경제 효과와 보건의료 전반에 걸친 사회•경제적 가치가 실현될 것으로 전망된다. 정밀 의료는 기존의 획일적인 치료 방식과 달리 환자 개개인의 유전적 정보와 질병 특성에 기반해 맞춤형 치료를 제공하는 새로운 접근 방식으로, 질환에 대해 근본적인 치료 가능성을 제시한다. 유전자 치료제, 표적 항체 치료제, 약물-기기 복합 치료제, 정밀 진단 기술이 정밀 의료의 대표적인 핵심 기술이다. 이번 보고서는 글로벌 컨설팅 회사 L.E.K. 컨설팅과 아시아태평양 지역 16인의 전문가 자문위원회가 함께 개발한 것으로, '전체 시스템 이익 모델링(whole system benefits modelling)'을 활용해 한국에서 정밀 의료가 가져올 경제 및 보건의료적 효과를 분석했다.
SINGAPORE, Aug. 13, 2025 -- KBP Biosciences Pte. Ltd. (the "Company") today issued a statement addressing a further decision by the Singapore International Commercial Court (the "Court") to maintain the temporary injunction against the Company and its founder, Dr. Huang Zhenhua ("Dr. Huang"), in support of arbitration proceedings respectively commenced by the Company and by Novo Nordisk A/S ("Novo Nordisk"). Following the Court's judgment today, the validity of the injunction application sought by Novo Nordisk will be determined via the arbitral
BEIJING, Aug. 13, 2025 -- A news report from chinadaily.com.cn In this documentary, three patients suffered from advanced heart failure share their stories of how China's independently-developed non-contact full maglev artificial heart brought hope to their lives. Click to learn more!
FREMONT, Calif., Aug. 13, 2025 -- Socket Mobile, a leading provider of data capture and delivery solutions, is pleased to announce that its SocketScan S370 and S550 readers have been officially approved by the Japanese government as certified My Number Card readers. Both products now appear on Japan's official list of eligible devices for accessing government services through the My Number Card program, an expansive and growing initiative designed to digitize citizen identification and enable secure access to public services. The My Number Card system is Japan's national identi
SEOUL, South Korea, Aug. 12, 2025 -- Willog, a leading provider of IoT and AI-powered supply chain intelligence solutions, today announced the signing of a Memorandum of Understanding (MOU) with the Republic of Korea (R.O.K.) Army Consolidated Supply Depot(Army Logistics Command). The partnership marks a significant step in the South Korean Army's ongoing digital transformation. Under the agreement, Willog will provide its cutting-edge technology and expertise to support the digital transformation of the Army's supply chain. This collaboration will involve joint research, techn
[ 메디채널 황정호 기자 ] EQT to sell Nexon Asia Pacific, a leading digital and IT services provider in Australia that delivers end-to-end solutions for the mid-market and enterprise market, to Adamantem Capital. During EQT's investment period, Nexon has transformed into a scaled and diversified business, with an expanded client base and strong financials to power its next phase of growth. With over 600 employees, Nexon now serves more than 1,000 mid-market and enterprise customers across Australia with its diversified offerings and end-markets. SYDNEY, Aug. 13, 2025 -- EQT is pleased to
[ 메디채널 김갑성 기자 ] - The combination of ASC47 low dose with tirzepatide in diet-induced obese (DIO) mice resulted in an 87% greater reduction in body weight compared to tirzepatide monotherapy. - ASC47 low dose in combination with tirzepatide demonstrated statistically significantly greater increase in efficacy than ASC47 low dose in combination with semaglutide, 87% vs 55%, respectively, in the DIO mouse model. - The combination of ASC47 low dose with tirzepatide also restored the body composition of obese mice to the level of healthy non-obese mice. A
[ 메디채널 김갑성 기자 ] 서울, 대한민국, 2025년 8월 13일 -- 오늘 8월 13일(수), HPTW 코리아가 공식 출범하며 한국 시장에서의 첫 발걸음을 내디뎠다. 이번 출범을 계기로, 글로벌 진단 모델 'Health Score'가 국내에 본격 도입된다. Health Score는 직원과 조직의 건강을 정밀하게 측정하고, 이를 성과와 연결해 위기 상황에서도 지속가능한 고성과 문화를 만들어가는 데 힘을 보태는 혁신적인 평가•인증 프로그램이다. 특히 이번 출범과 함께 'Make Work Healthy 특별강연 및 Health Score 온라인 진단 인증설명회'가 열린다. Health Score를 만든 창시자이자 『Make Work Healthy』의 저자인 존 라이언(John Ryan)이 직접 발표하며, 참가자는 무료로 신청 가능하고, 『Make Work Healthy』 도서도 증정된다. HPTW는 아일랜드 Dublin University에 본사를 두고, 영국•스칸디나비아•멕시코•브라질•필리핀•아랍에미리트•루마니아 등 전 세계 20여 개국에서 운영되고 있다. 글로벌 파트너인 Roffey Park Institute와 협력해 다수의